Immunogenicity of tumour necrosis factor inhibitors in patients with psoriasis receiving long-term treatment

被引：0
|
作者：
Meyer, M. W. [1 ]
Zachariae, C. [1 ]
Bendtzen, K. [2 ]
Skov, L. [1 ]
机构：
[1] Copenhagen Univ Hosp Gentofte, Dept Dermatoallergol, Copenhagen, Denmark
[2] Rigshosp, Natl Univ Hosp, Inst Inflammat Res, DK-2100 Copenhagen, Denmark
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2011年 / 165卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：E17 / E17
页数：1
相关论文
共 50 条
  • [1] Lack of Anti-drug Antibodies in Patients with Psoriasis Well-controlled on Long-term Treatment with Tumour Necrosis Factor Inhibitors
    Meyer, Martin W.
    Zachariae, Claus
    Bendtzen, Klaus
    Skov, Lone
    ACTA DERMATO-VENEREOLOGICA, 2012, 92 (04) : 362 - 364
  • [2] PREDICTING SUCCESSFUL LONG-TERM TREATMENT WITH TUMOUR NECROSIS FACTOR ALPHA INHIBITORS IN PATIENTS WITH PSORIATIC ARTHRITIS
    Fagerli, Karen M.
    Watson, Kath D.
    Packham, Jon
    Symmons, Deborah P. M.
    Hyrich, Kimme L.
    RHEUMATOLOGY, 2015, 54 : 134 - 135
  • [3] Predicting Successful Long-Term Treatment with Tumour Necrosis Factor-Alpha Inhibitors in Patients with Psoriatic Arthritis
    Fagerli, Karen M.
    Watson, Kath D.
    Packham, Jonathon
    Symmons, Deborah P. M.
    Hyrich, Kimme L.
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S679 - S680
  • [4] Ustekinumab in the treatment of psoriasis in patients resistant to tumour necrosis factor-α inhibitors
    O'Shea, S. J.
    Rogers, S.
    Kirby, B.
    BRITISH JOURNAL OF DERMATOLOGY, 2010, 163 (02) : 444 - 444
  • [5] The risk of malignancy in patients with psoriasis treated with long-term tumour necrosis factor-alpha inhibitors: a systematic review and meta-analysis
    Wu, Wen-Ting
    Chiang, Ming-Che
    Huang, Yu-Chen
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2025,
  • [6] Long-term safety and effectiveness of tumour necrosis factor inhibitors in systemic sclerosis patients with inflammatory arthritis
    Omair, M. A.
    Phumethum, V.
    Johnson, S. R.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2012, 30 (02) : S55 - S59
  • [7] LEISHMANIASIS IN PATIENTS ON TUMOUR NECROSIS FACTOR INHIBITORS TREATMENT
    Montolio Chiva, L.
    Valls Pascual, E.
    Ybanez Garcia, D.
    Martinez Ferrer, A.
    Fernandez Matilla, M.
    Lluch Pons, J.
    Juanola Roura, X.
    Marcoval Caus, J.
    Garcia Briz, M-I
    Paredes Arquiola, J. M.
    Lopez Cruz, I.
    Salazar Cifre, A.
    Aguilar Zamora, M.
    Orenes Vera, A. V.
    Garcia Sendra, A.
    Nunez Monje, V.
    Torner Hernandez, I.
    Alegre Sancho, J. J.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1063 - 1063
  • [8] PREDICTING DRUG IMMUNOGENICITY TO TUMOUR NECROSIS FACTOR INHIBITORS IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Alshehri, Mohammed
    Nair, Nisha
    Yap, Chuan Fu
    Isaacs, John D.
    Hyrich, Kimme
    Morgan, Ann W.
    Wilson, Anthony G.
    Barton, Anne
    Plant, Darren
    RHEUMATOLOGY, 2022, 61 : I13 - I13
  • [9] Genetic markers of treatment response to tumour necrosis factor-α inhibitors in the treatment of psoriasis
    Ryan, C.
    Kelleher, J.
    Fagan, M. F.
    Rogers, S.
    Collins, P.
    Barker, J. N. W. N.
    Allen, M.
    Hagan, R.
    Renfro, L.
    Kirby, B.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2014, 39 (04) : 519 - 524
  • [10] Remission of photosensitivity following treatment of psoriasis vulgaris with tumour necrosis factor inhibitors
    Viguier, M.
    Jeanmougin, M.
    Begon, E.
    Verola, O.
    Dubertret, L.
    Bachelez, H.
    BRITISH JOURNAL OF DERMATOLOGY, 2007, 157 (03) : 625 - 627
12345